Promethium
About Promethium
Promethium is QC Ware’s new software-as-a-service (SaaS) quantum chemistry platform introduced in April 2024 that promises to significantly speed up discovery processes in pharmaceutical, chemical, and material sectors. The platform provides quantum-enhanced computational chemistry tools for molecular simulation, drug discovery, and materials design. Promethium combines quantum algorithms with classical computational chemistry methods to achieve more accurate and faster molecular property predictions. The platform targets researchers and companies developing new drugs, catalysts, and advanced materials. QC Ware’s Promethium platform is cloud-based, providing easy access to quantum chemistry capabilities without requiring specialized quantum computing expertise. The software integrates with existing computational chemistry workflows and provides validation against experimental data. QC Ware, founded in 2014 and headquartered in Mountain View, California, specializes in enterprise quantum applications.
2025 Developments: The company continues to enhance its quantum software platform and developer tools in 2025. Focus remains on improving algorithm efficiency and expanding use case applications. Active engagement with the quantum developer community drives product evolution.
Company Information
- Founded: 2024
- Country: United States
- Website: https://www.qcware.com
- Categories: quantum chemistry, quantum software
Key People
Matt Johnson (Co-founder), Randy Correll (Co-founder)
Related Companies
Explore other quantum computing companies in similar categories or regions.